|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2007-4-6
|
|
pubmed:abstractText |
New Zealand has experienced an epidemic of Neisseria meningitidis dominated by strain B:4:P1.7b,4 since 1991. Children younger than 5 years are at highest risk. Previous serogroup B outer membrane vesicle (OMV) strain specific vaccines have shown variable efficacy in this age group.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0891-3668
|
|
pubmed:author |
pubmed-author:AabergeIngeborgI,
pubmed-author:CrengleSueS,
pubmed-author:JacksonCatherineC,
pubmed-author:LennonDianaD,
pubmed-author:MartinDianaD,
pubmed-author:MulhollandKimK,
pubmed-author:O'HallahanJaneJ,
pubmed-author:OsterPhilippP,
pubmed-author:ReidStewartS,
pubmed-author:StewartJoannaJ,
pubmed-author:TilmanSandrineS,
pubmed-author:WongSharonS
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
345-50
|
|
pubmed:meshHeading |
pubmed-meshheading:17414400-Antibodies, Bacterial,
pubmed-meshheading:17414400-Blood Bactericidal Activity,
pubmed-meshheading:17414400-Child, Preschool,
pubmed-meshheading:17414400-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:17414400-Female,
pubmed-meshheading:17414400-Humans,
pubmed-meshheading:17414400-Infant,
pubmed-meshheading:17414400-Male,
pubmed-meshheading:17414400-Meningococcal Infections,
pubmed-meshheading:17414400-Meningococcal Vaccines,
pubmed-meshheading:17414400-Neisseria meningitidis, Serogroup B,
pubmed-meshheading:17414400-New Zealand,
pubmed-meshheading:17414400-Single-Blind Method,
pubmed-meshheading:17414400-Species Specificity,
pubmed-meshheading:17414400-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
New zealand epidemic strain meningococcal B outer membrane vesicle vaccine in children aged 16-24 months.
|
|
pubmed:affiliation |
The University of Auckland, Auckland, New Zealand.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|
